Clinical Trial

Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated September 19, 2024 completion). Its status may not reflect the trial's current state.
Summary
Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.
Trial Details
NCT Number NCT06565845
Lead Sponsor First Affiliated Hospital of Harbin Medical University
Conditions Granulomatous Mastitis
Enrollment 350 participants
Start Date 2024-08-19
Primary Completion 2024-09-19 (estimated)
Study Completion 2024-10-19 (estimated)
Updated on ClinicalTrials.gov 2024-08-22